Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Simard

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
Breast Cancer Research and Treatment|August 28, 2010
The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriersBella Kaufman, Yael Laitman, Elad Ziv, et al.
BMJ Open|May 2, 2025
Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional studyArian Omeranovic, Julie Lapointe, Philippe Fortier, et al.
International Journal of Cancer|September 4, 2018
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohortJingmei Li, Wei Xiong Wen, Martin Eklund, et al.
Journal of Medical Genetics|September 26, 2022
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidenceAndrew Lee, Nasim Mavaddat, Alex Cunningham, et al.
International Journal of Epidemiology|December 25, 2019
A Mendelian randomization analysis of circulating lipid traits and breast cancer riskAlicia Beeghly-Fadiel, Nikhil K Khankari, Ryan J Delahanty, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
Journal of Personalized Medicine|February 5, 2021
Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in CanadaCynthia Mbuya Bienge, Nora Pashayan, Jennifer D Brooks, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 17, 2023
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction ModelNasim Mavaddat, Lorenzo Ficorella, Tim Carver, et al.
Cancer Research|February 12, 2004
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?Csilla I Szabo, Mieke Schutte, Annegien Broeks, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
Breast Cancer Research and Treatment|August 28, 2010
The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriersBella Kaufman, Yael Laitman, Elad Ziv, et al.
BMJ Open|May 2, 2025
Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional studyArian Omeranovic, Julie Lapointe, Philippe Fortier, et al.
International Journal of Cancer|September 4, 2018
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohortJingmei Li, Wei Xiong Wen, Martin Eklund, et al.
Journal of Medical Genetics|September 26, 2022
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidenceAndrew Lee, Nasim Mavaddat, Alex Cunningham, et al.
International Journal of Epidemiology|December 25, 2019
A Mendelian randomization analysis of circulating lipid traits and breast cancer riskAlicia Beeghly-Fadiel, Nikhil K Khankari, Ryan J Delahanty, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
Journal of Personalized Medicine|February 5, 2021
Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in CanadaCynthia Mbuya Bienge, Nora Pashayan, Jennifer D Brooks, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 17, 2023
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction ModelNasim Mavaddat, Lorenzo Ficorella, Tim Carver, et al.
Cancer Research|February 12, 2004
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?Csilla I Szabo, Mieke Schutte, Annegien Broeks, et al.
Pageof 29